Study reveals safety of MS drugs during breastfeeding in child’s early years of life

FHS
March 5, 2024
3:10 am

Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024.

GSK to put £50M into Cambridge University partnership; Angelini’s new deal

Plus, news about Takeda, Foresee Pharmaceuticals and Capricor Therapeutics: GSK, Cambridge University team up on immune diseases: The UK drugmaker is pouring £50 million …

October 22, 2024

Antipsychotics linked to increased behavioral problems in nursing homes

A new study conducted by researchers at the University of Waterloo analyzed data from nearly 500,000 Canadian patients who lived in nursing homes across Canada

December 6, 2024

LTS wins $1.2m grant to develop mRNA therapy patches

Share this article The Bill & Melinda Gates Foundation will be dispersed over 15 months. Image Credit: uniqueton / Shutterstock. German pharmaceutical company Lohmann Therapie-Systeme

December 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.